Jinkosolar Holdings Co (JKS)
NYSE: JKS · Semiconductors & Related Devices · Jiangxi Province, CN · filing with the SEC since 2010
Who owns Jinkosolar Holdings Co
As filed with the SECHolders of 5% or more
2
Kangping Chen holds 13.1% of Ordinary Shares, Par Value US$0.00002 Per Share ("Ordinary Shares"), as its SCHEDULE 13D/A filed Oct 1, 2026 says.
Directors and officers
8
report now, of 8 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Kangping Chen
SCHEDULE 13D/A · filed Oct 1, 2026 · Ordinary Shares, Par Value US$0.00002 Per Share ("Ordinary Shares")
Peaky Investments Limited
SCHEDULE 13G · filed Jul 29, 2025 · Ordinary shares, par value US$0.00002 per share
What JKS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Jiangxi Jinko
An entity · legal entity · owns, named in the 20-F filed Apr 29, 2026
Jinko Power Co Ltd
An entity · legal entity · owns, named in the 20-F filed Apr 29, 2026
JinkoSolar (Sichuan) Co., Ltd.
An entity · consolidated entity · owns, named in the 20-F filed Apr 29, 2026
Jiangxi Raoxin New Energy Materials Co., Ltd
An investee · investee · invested in, named in the 20-F filed Apr 29, 2026
Jinko ShangRao
An investee · investee · invested in, named in the 20-F filed Apr 29, 2026
Jinkosolar Energy Manufacturing Company
An investee · investee · invested in, named in the 20-F filed Apr 29, 2026
JinkoSolar International Development Limited
An investee · investee · invested in, named in the 20-F filed Apr 29, 2026
Lifecome Biochemical Co., Ltd
An investee · investee · invested in, named in the 20-F filed Apr 29, 2026
67 subsidiaries in 14 countries, from the list filed with the 20-F filed Apr 29, 2026.
Insider tradesForm 4
4sales
1purchases
0sales on a scheduled plan
3people selling
$33.4Msold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 8 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Li Xianhua | director | 1 | $32.7M | 0 | 0 | $0 |
| Siew Wing Keong | director | 2 | $700,000 | 0 | 0 | $0 |
| Markscheid Stephen | director | 1 | $100,000 | 0 | 1 | $100,000 |